申请人:HOWARD HUGHES MEDICAL INSTITUTE
公开号:US10407399B2
公开(公告)日:2019-09-10
The presently-disclosed subject matter relates to analyte-activated photolabile compounds. The compounds include the formula: wherein Z includes a maskable molecule; L is selected from a bond, C, C(O), O, alkyl, (O)alkyl, and alkoxy; R1 is selected from H, halogen, alkyl, and acyl; each R2 is independently selected from H, alkyl, aryl, and acyl, and is optionally substituted with one or more heteroatoms independently selected from COOH and COO(alkyl); and R3 is selected from H, alkyl, aryl, halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, CHO, COOH, COO(alkyl), COO(aryl), PO3H2, and SO3H, and is optionally substituted with one or more heteroatoms independently selected from N, O, and S, halogen, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO2, CHO, COO, COOH, COO(alkyl), COO(aryl), C(O)NR2, PO3H2, and/or SO3H. Also provided are methods of detecting calcium and treating a subject with the analyte-activated photolabile compounds.
本公开的主题涉及分析物活化的可光化化合物。这些化合物包括式其中 Z 包括可掩蔽分子;L 选自键、C、C(O)、O、烷基、(O)烷基和烷氧基;R1 选自 H、卤素、烷基和酰基;每个 R2 独立选自 H、烷基、芳基和酰基,并任选被一个或多个独立选自 COOH 和 COO(烷基)的杂原子取代;R3 选自 H、烷基、芳基、卤素、CN、OH、O(烷基)、O(芳基)、SH、S(烷基)、S(芳基)、胺、CHO、COOH、COO(烷基)、COO(芳基)、PO3H2 和 SO3H、并任选被一个或多个独立选自 N、O 和 S、卤素、OH、O(烷基)、O(芳基)、SH、S(烷基)、S(芳基)、胺、NO2、CHO、COO、COOH、COO(烷基)、COO(芳基)、C(O)NR2、PO3H2 和/或 SO3H 的杂原子取代。此外,还提供了检测钙和用分析物活化的可光化化合物治疗受试者的方法。